Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...
Symptom prescription is an intervention described by the school of Palo Alto in California and has been utilized in a myriad of clinical contexts as a psychotherapeutic tool. There was a significant ...